☆ 4.6 Letter

Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis

EUROPEAN RESPIRATORY JOURNAL (2014)

期刊

EUROPEAN RESPIRATORY JOURNAL

卷 43, 期 5, 页码 1530-1532

出版社

EUROPEAN RESPIRATORY SOC JOURNALS LTD

DOI: 10.1183/09031936.00131713

关键词

-

类别

Respiratory System

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Critical Care Medicine

Early Radiographic Progression of Scleroderma Lung Disease Predicts Long-term Mortality

Elizabeth R. Volkmann, Donald P. Tashkin, Michael D. Roth, Jonathan Goldin, Grace H. J. Kim

Summary: This study demonstrates that short-term changes in radiographic measures of interstitial lung disease (ILD) can predict long-term survival in patients with systemic sclerosis (SSc), indicating that radiographic end points may serve as surrogates for mortality in SSc-ILD.

CHEST (2022)

添加到收藏夹

Review Medicine, General & Internal

Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis-Interstitial Lung Disease: A Systematic Review

Nicholas Landini, Martina Orlandi, Cosimo Bruni, Edoardo Carlesi, Cosimo Nardi, Linda Calistri, Giovanni Morana, Sara Tomassetti, Stefano Colagrande, Marco Matucci-Cerinic

Summary: The extent and severity of ILD can predict mortality in SSc-ILD patients on CT, as well as densitometric analysis parameters, fibrotic extent, and reticulation extent. Extensive ILD is also associated with death, need for supplemental oxygen, or lung transplantation. Honeycombing extent is a predictor for respiratory mortality.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Respiratory System

Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression

Carmel J. W. Stock, Rachel K. Hoyles, Cecile Daccord, Maria Kokosi, Dina Visca, Angelo De Lauretis, Veronica Alfieri, Vasilis Kouranos, George Margaritopoulos, Peter M. George, Philip L. Molyneaux, Felix Chua, Toby M. Maher, David J. Abraham, Voon Ong, Jackie Donovan, Piersante Sestini, Christopher P. Denton, Athol U. Wells, Elisabetta A. Renzoni

Summary: The study results indicate that serum KL-6 predicts decline in lung function in systemic sclerosis-associated interstitial lung disease (SSc-ILD) patients, suggesting its clinical utility in risk stratification for progressive SSc-ILD. KL-6 is particularly useful for predicting decline in lung function in patients who require prognostic assessment for SSc-ILD progression.

RESPIROLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease

Satoshi Watanabe, Kazumasa Kase, Keigo Saeki, Noriyuki Ohkura, Akari Murata, Yuko Waseda, Hazuki Takato, Yukari Ichikawa, Masahide Yasui, Kazuo Kasahara

Summary: This study found that changes in KL-6 level can serve as a useful indicator for predicting disease progression in patients with SSc-ILD. Specifically, Delta KL-6 level greater than 193 U/mL and diffuse cutaneous SSc were identified as independent predictors for the progression of SSc-ILD.

RESPIRATORY MEDICINE (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis

Chiara Pellicano, Giorgia Leodori, Amalia Colalillo, Luca Navarini, Antonietta Gigante, Edoardo Rosato

Summary: The study found that serum resistin levels were significantly higher in systemic sclerosis (SSc) patients compared to healthy controls, but lower in patients with early capillaroscopic pattern. During a 52-week follow-up, about 48.6% of patients developed new digital ulcers (DUs), with those patients having significantly higher resistin levels. Increased serum resistin level was identified as a predictive marker for new DUs in SSc patients.

CLINICAL AND EXPERIMENTAL MEDICINE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Serum microRNAs in Systemic Sclerosis, Associations with Digital Vasculopathy and Lung Involvement

Anna Wajda, Marcela Walczyk, Ewa Dudek, Barbara Stypinska, Aleksandra Lewandowska, Katarzyna Romanowska-Prochnicka, Marek Chojnowski, Marzena Olesinska, Agnieszka Paradowska-Gorycka

Summary: Systemic sclerosis (SSc) is a rare multisystem chronic disease with autoimmune features. In this study, the expression profile of selected microRNAs, including miR-126, -132, -143, -145, -155, -181a, -29a and -3148, was investigated in SSc patients compared to healthy controls. The results showed that the expression of these microRNAs was significantly altered in SSc patients, with miR-181a downregulated and miR-132, miR-143, miR-145 and miR-155 overexpressed. These findings suggest that these microRNAs may serve as potential biomarkers for SSc diagnosis and disease progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Dermatology

Serum S100A12 levels: Possible association with skin sclerosis and interstitial lung disease in systemic sclerosis

Jun Omatsu, Ryosuke Saigusa, Takuya Miyagawa, Yuki Fukui, Satoshi Toyama, Kentaro Awaji, Tetsuya Ikawa, Yuta Norimatsu, Ayumi Yoshizaki, Shinichi Sato, Yoshihide Asano

Summary: The expression levels of S100A12 are significantly elevated in systemic sclerosis (SSc) patients, especially in lesional skin and bulk skin. Serum S100A12 levels are correlated with the severity of skin involvement and the presence of interstitial lung disease in SSc patients.

EXPERIMENTAL DERMATOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

An interleukin 6 responsive plasma cell signature is associated with disease progression in systemic sclerosis interstitial lung disease

Guiquan Jia, Thirumalai R. Ramalingam, Jason Vander Heiden, Xia Gao, Daryle Depianto, Katrina B. Morshead, Zora Modrusan, Nandhini Ramamoorthi, Paul Wolters, Celia Lin, Dinesh Khanna, Joseph R. Arron

Summary: This study analyzed skin biopsy samples from systemic sclerosis patients and found that treatment with tocilizumab may be related to plasma cell genes. The study also revealed increased expression levels of plasma cell genes in fibrotic interstitial lung diseases. These findings provide new insights into disease progression and the mechanism of action of tocilizumab.

ISCIENCE (2023)

添加到收藏夹

Article Respiratory System

Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis

Shuo Liu, Melody P. Chung, Brett Ley, Sarah French, Brett M. Elicker, David F. Fiorentino, Lorinda S. Chung, Francesco Boin, Paul J. Wolters

Summary: Peripheral blood leucocyte telomere length (PBL-TL) is associated with progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD), with shorter PBL-TL potentially indicating higher risk of SSc-ILD progression. These findings suggest that telomere dysfunction may be associated with SSc-ILD progression, and PBL-TL measurement may be useful for stratifying risk for SSc-ILD progression.

THORAX (2021)

添加到收藏夹

Article Medicine, General & Internal

Serum TARC Levels in Patients with Systemic Sclerosis: Clinical Association with Interstitial Lung Disease

Ai Kuzumi, Ayumi Yoshizaki, Satoshi Ebata, Takemichi Fukasawa, Asako Yoshizaki-Ogawa, Yoshihide Asano, Koji Oba, Shinichi Sato

Summary: The study found that serum TARC levels were elevated in SSc patients, especially in those with the diffuse subtype and SSc-associated ILD. However, there was no significant correlation between serum TARC levels with pulmonary function and serum levels of interleukin-13. Longitudinal study showed that serum TARC levels did not predict the onset or progression of SSc-ILD in patients with SSc.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease

Antonio Giovanni Versace, Alessandra Bitto, Carmelo Ioppolo, Caterina Oriana Aragona, Daniela La Rosa, William Neal Roberts, Tommaso D'Angelo, Antonella Cinquegrani, Santa Cirmi, Natasha Irrera, Michele Navarra, Salvatore Corrao, Sebastiano Gangemi, Gianluca Bagnato

Summary: The study aimed to investigate the levels of IL-33 and IL-13 in patients with diffuse SSc and interstitial lung disease (SSc-ILD) compared to SSc patients without ILD and healthy controls. The results showed that both IL-13 and IL-33 levels were elevated in SSc patients and were significantly associated with each other. Additionally, higher levels of IL-33 and IL-13 were observed in SSc patients with reduced pulmonary function compared to those with normal lung function. This suggests that the IL-13/IL-33 axis may play a role in the development and severity of SSc-ILD.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease

Giuliana Cerro-Chiang, Matthew Ayres, Alejandro Rivas, Tahmineh Romero, Sarah J. Parker, Mitra Mastali, David Elashoff, Peter Chen, Jennifer E. Van Eyk, Paul J. Wolters, Francesco Boin, Tanzira Zaman

Summary: This study aimed to identify blood protein biomarkers associated with the progression of SSc-ILD. Serum proteins were profiled and analyzed for their association with disease progression. Results showed 29 proteins associated with progression, but these associations did not remain significant after adjusting for multiple testing. Unsupervised clustering analysis also did not reveal significant heterogeneity between the subjects.

SCIENTIFIC REPORTS (2023)

添加到收藏夹

Article Rheumatology

Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease

Cosimo Bruni, Mariaelena Occhipinti, Michael Pienn, Gianna Camiciottoli, Maurizio Bartolucci, Silvia Laura Bosello, Christian Payer, Zoltan Balint, Anna Rita Larici, Alessandra Tottoli, Lorenzo Tofani, Enrico De Lorenzis, Gemma Lepri, Silvia Bellando-Randone, Amelia Spinella, Dilia Giuggioli, Francesco Masini, Giovanna Cuomo, Federico Lavorini, Stefano Colagrande, Horst Olschewski, Marco Matucci-Cerinic

Summary: Recent advancements have made it possible to quantitatively assess lung vascular and parenchymal changes in thoracic CT images using automated software tools. In this study, the researchers investigated the vessel parameters of patients with SSc and correlated them with interstitial lung disease (ILD) features. The results showed that the CT vessel parameters increased in parallel with ILD extent and functional impairment, suggesting that they may serve as a biomarker of SSc-ILD severity.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Estimated glomerular filtration rate and renal resistive index as possible predictive markers of mortality in systemic sclerosis

Giorgia Leodori, Chiara Pellicano, Antonietta Gigante, Edoardo Rosato

Summary: This study evaluated the role of renal resistance indices and estimated glomerular filtration rate as predictive markers of mortality in systemic sclerosis patients over a 10-year follow-up. It was found that eGFR was a predictive marker of mortality due to SSc and all causes, while RRI was a predictive marker of mortality due to all causes.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis

Liticia Chikhoune, Thierry Brousseau, Sandrine Morell-Dubois, Meryem Maud Farhat, Helene Maillard, Emmanuel Ledoult, Marc Lambert, Cecile Yelnik, Sebastien Sanges, Vincent Sobanski, Eric Hachulla, David Launay

Summary: This study aimed to assess the association of routine laboratory parameters with the severity and progression of systemic sclerosis (SSc). The results showed that certain routine laboratory parameters were associated with different clinical presentations and outcomes of SSc.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Respiratory System

European Respiratory Society statement on familial pulmonary fibrosis

Raphael Borie, Caroline Kannengiesser, Katerina Antoniou, Francesco Bonella, Bruno Crestani, Aurelie Fabre, Antoine Froidure, Liam Galvin, Matthias Griese, Jan C. Grutters, Maria Molina-Molina, Venerino Poletti, Antje Prasse, Elisabetta Renzoni, Jasper van der Smagt, Coline H. M. van Moorsel

Summary: The discovery of gene mutations that cause pulmonary fibrosis confirms the genetic predisposition to this condition. While genetic sequencing is already part of routine clinical practice for familial pulmonary fibrosis cases in some countries, it has not been widely incorporated into interstitial lung disease services and lacks international consensus.

EUROPEAN RESPIRATORY JOURNAL (2023)

添加到收藏夹

Article Allergy

The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease

Bas Smits, Sigune Goldacker, Suranjith Seneviratne, Marion Malphettes, Hilary Longhurst, Omar E. Mohamed, Carla Witt-Rautenberg, Lucy Leeman, Eva Schwaneck, Isabelle Raymond, Kilifa Meghit, Annette Uhlmann, Christine Winterhalter, Joris van Montfrans, Marion Klima, Sarita Workman, Claire Fieschi, Lorena Lorenzo, Sonja Boyle, Shamin Onyango-Odera, Suzanne Price, Marc Schmalzing, Valerie Aurillac, Antje Prasse, Ieneke Hartmann, Jennifer J. Meerburg, Mariette Kemner-van de Corput, Harm Tiddens, Bodo Grimbacher, Peter Kelleher, Smita Y. Patel, Anne-Sophie Korganow, Jean-Francois Viallard, Hans-Peter Tony, Claire Bethune, Hendrik Schulze-Koops, Torsten Witte, Aarnoud Huissoon, Helen Baxendale, Sofia Grigoriadou, Eric Oksenhendler, Siobhan O. Burns, Klaus Warnatz

Summary: This study analyzed the effect of high-dose corticosteroids on granulomatous and lymphocytic interstitial lung disease (gl-ILD) using high-resolution computed tomography (HRCT) scans and pulmonary function tests (PFT). The results showed that high-dose corticosteroid treatment significantly improved HRCT scores and lung function, achieving long-term remission in 42% of patients with gl-ILD. However, low-dose maintenance therapy was not beneficial and had poor efficacy in relapsing disease.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

添加到收藏夹

Article Medicine, Research & Experimental

microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis

Farida Ahangari, Nathan L. Price, Shipra Malik, Maurizio Chioccioli, Thomas Barnthaler, Taylor S. Adams, Jooyoung Kim, Sai Pallavi Pradeep, Shuizi Ding, Carlos Cosmos Jr., Kadi-Ann S. Rose, John E. McDonough, Nachelle R. Aurelien, Gabriel Ibarra, Norihito Omote, Jonas C. Schupp, Giuseppe DeIuliis, Julian A. Villalba Nunez, Lokesh Sharma, Changwan Ryu, Charles S. Dela Cruz, Xinran Liu, Antje Prasse, Ivan Rosas, Raman Bahal, Carlos Fernandez-Hernando, Naftali Kaminski

JCI INSIGHT (2023)

添加到收藏夹

Article Medicine, General & Internal

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis The ISABELA 1 and 2 Randomized Clinical Trials

Toby M. Maher, Paul Ford, Kevin K. Brown, Ulrich Costabel, Vincent Cottin, Sonye K. Danoff, Irene Groenveld, Eric Helmer, R. Gisli Jenkins, Julie Milner, Geert Molenberghs, Bjorn Penninckx, Matthew J. Randall, Bernt Van den Blink, Ann Fieuw, Charlotte Vandenrijn, Sanda Rocak, Ineke Seghers, Lixin Shao, Amit Taneja, Garrit Jentsch, Timothy R. Watkins, Wim A. Wuyts, Michael Kreuter, Nadia Verbruggen, Niyati Prasad, Marlies S. Wijsenbeek

Summary: This study aimed to assess the efficacy and safety of the autotaxin inhibitor ziritaxestat in patients with idiopathic pulmonary fibrosis (IPF). The study found that ziritaxestat did not improve clinical outcomes compared with placebo in patients with IPF.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

添加到收藏夹

Article Rheumatology

Practicable diagnostics of Sjogren's syndrome in interstitial lung disease-A discussion article

Martin Aringer, Dirk Koschel, Thomas Doerner, Philipp Sewerin, Antje Prasse, Torsten Witte

Summary: Sjogren's syndrome is a potential autoimmune cause of interstitial lung disease. The diagnostic pathway for this syndrome is not well-defined compared to other autoimmune diseases. Subjective sicca symptoms and specific autoantibodies have limitations in their sensitivity and/or specificity as screening tests. To address this, a consensus has been developed to include additional antibodies and objective measures in the diagnosis.

ZEITSCHRIFT FUR RHEUMATOLOGIE (2023)

添加到收藏夹

Correction Respiratory System

Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis S2k Guideline of the German Respiratory Society (vol 77, pg 94, 2023)

Juergen Behr, Francesco Bonella, Bjoern C. Frye, Andreas Guenther, Lars Hagmeyer, Joerg Henes, Philipp Klemm, Dirk Koschel, Michael Kreuter, Gabriela Leuschner, Dennis Nowak, Antje Prasse, Bernd Quadder, Helmut Sitter, Ulrich Costabel

PNEUMOLOGIE (2023)

添加到收藏夹

Article Respiratory System

Consensus guideline on the interdisciplinary diagnosis of interstitial lung diseases

[Anonymous]

Summary: The evaluation of ILD patients involves assessing clinical, radiological, and histopathological data. This position statement from ILD experts provides guidance on diagnostic modalities to be used, including clinical assessment, rheumatological evaluation, radiological examinations, histopathologic sampling, and multidisciplinary team discussions.

PNEUMOLOGIE (2023)

添加到收藏夹

Editorial Material Respiratory System

SARS-CoV-2-Infection and Interstitial Lung Disease: Position paper of the German Respiratory Society

Jurgen Behr, Melanie Berger, Torsten Gerriet Blum, Francesco Bonella, Julien Dinkel, Sven Glaeser, Lars Hagmeyer, Nikolaus Kneidinger, Dirk Koschel, Antje Prasse, Hortense Slevogt, Elvira Stacher-Priehse, Holger Woehrle, Michael Kreuter

Summary: The SARS-CoV-2 pandemic has had a significant impact on the diagnosis and treatment of ILDs. Viral pneumonias caused by the delta variant exacerbated pre-existing ILDs and led to the discovery of previously subclinical ILDs. The effect of SARS-CoV-2 infection on the progression of ILDs is unpredictable and poses challenges to medical professionals.

PNEUMOLOGIE (2023)

添加到收藏夹

Article Respiratory System

Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis

Juergen Behr, Francesco Bonella, Bjoern C. Frye, Andreas Guenther, Lars Hagmeyer, Joerg Henes, Philipp Klemm, Dirk Koschel, Michael Kreuter, Gabriela Leuschner, Dennis Nowak, Antje Prasse, Bernd Quadder, Helmut Sitter, Ulrich Costabel

PNEUMOLOGIE (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics

Martin Kolb, Kevin R. Flaherty, Rafael S. Silva, Antje Prasse, Carlo Vancheri, Heiko Mueller, Kamila Sroka-Saidi, Athol U. Wells, INBUILD Trial Investigators

Summary: The study found that nintedanib consistently slowed the rate of decline in forced vital capacity (FVC) in patients with progressive pulmonary fibrosis. The effectiveness of nintedanib in reducing the progression of interstitial lung disease (ILD) was also consistent across subgroups based on different baseline characteristics. This supports the use of nintedanib as a treatment for progressive pulmonary fibrosis.

ADVANCES IN THERAPY (2023)

添加到收藏夹

Editorial Material Critical Care Medicine

When Development of the Alveolar Gas Exchange Unit Fails Universal Single-Cell Lessons from Rare Monogenic Disorders

Jonas C. Schupp, Naftali Kaminski

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

添加到收藏夹

Letter Critical Care Medicine

Alveolar Vascular Remodeling in Nonspecific Interstitial Pneumonia: Replacement of Normal Lung Capillaries with COL15A1-Positive Endothelial Cells

Jonas C. Schupp, Edward P. Manning, Maurizio Chioccioli, Jan C. Kamp, Leonard Christian, Changwan Ryu, Erica Herzog, Mark P. Kuehnel, Antje Prasse, Naftali Kaminski, Danny D. Jonigk, Robert J. Homer

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

添加到收藏夹

Editorial Material Medicine, General & Internal

An Introduction to pulmonary Hemorrhage from a Pulmonology Perspective

Jannik Ruwisch, Tobias Welte, Antje Prasse

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.